Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form

Thermodynamic stability order of tolbutamide between polymorphs was evaluated using calorimetry and spectroscopic analysis. The heat of solution (Δ H) of Forms I–III measurements were carried out in dimethylsulfoxide between 298.2 K and 319.2 K. It was found that the Δ H of Forms II and III was incr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2009-03, Vol.369 (1), p.12-18
Hauptverfasser: Hasegawa, Gen, Komasaka, Takao, Bando, Rui, Yoshihashi, Yasuo, Yonemochi, Etsuo, Fujii, Kotaro, Uekusa, Hidehiro, Terada, Katsuhide
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 18
container_issue 1
container_start_page 12
container_title International journal of pharmaceutics
container_volume 369
creator Hasegawa, Gen
Komasaka, Takao
Bando, Rui
Yoshihashi, Yasuo
Yonemochi, Etsuo
Fujii, Kotaro
Uekusa, Hidehiro
Terada, Katsuhide
description Thermodynamic stability order of tolbutamide between polymorphs was evaluated using calorimetry and spectroscopic analysis. The heat of solution (Δ H) of Forms I–III measurements were carried out in dimethylsulfoxide between 298.2 K and 319.2 K. It was found that the Δ H of Forms II and III was increased nearly parallel with a temperature rise. However, change of the Δ H of Form I with a temperature rise was not in correspondence with that of other forms. Solubility data confirmed the change in Δ H of Form I around 308.2 K. XRD–DSC measurement of Form I detected a polymorphic transformation (Form I L → unknown form) at 311 K. Obtained data suggested that the new crystal form (Form I H) would exist above 311 K, and the order of thermodynamic stability was “Form III < Form I L < Form II” below the transition temperature, on the other hand, the order was changed in “Form I L and Form I H < Form III < Form II” above the transition temperature. The crystal structure of Form I H was determined by measurement of PXRD pattern on BL19B2 at SPring-8, and the change in the solid-state NMR spectrum confirmed the transformation of the crystal structure of Form I L.
doi_str_mv 10.1016/j.ijpharm.2008.10.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66985510</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517308007291</els_id><sourcerecordid>66985510</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-c82a2c2c8882493eaa0e82c82c559e95bbe03a703c220a912b432d63d14f33c43</originalsourceid><addsrcrecordid>eNqFkM1q3DAURkVpaKZpH6FFm3bniX4sWV6FEpo2ECiEZC1k-ZpoKluuJKfM20dmTLrsSnyX811dDkKfKNlTQuXlYe8O85OJ454RospsT6h6g3ZUNbzidSPfoh3hjaoEbfg5ep_SgRAiGeXv0DltCZMNZzvk7wGejV9MdmHCYcAp-KVz3uXjmnLw3ZLN6HrAZurxHPxxDHF-chbnaKY0hDieukMMI74pEd-WGl6m31P4O2Ebjykbj1fwAzobjE_wcXsv0OPN94frn9Xdrx-319_uKisIz5VVzDDLrFKK1S0HYwioEpkVooVWdB0QbhrCLWPEtJR1NWe95D2tB85tzS_Q19PeOYY_C6SsR5cseG8mCEvSUrZKCEoKKE6gjSGlCIOeoxtNPGpK9KpZH_SmWa-a13HRXHqftw-WboT-X2vzWoAvG2CSNX4oqqxLrxyjTEom1kuvThwUHc8Ook7WwWShdxFs1n1w_znlBREXn8c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66985510</pqid></control><display><type>article</type><title>Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hasegawa, Gen ; Komasaka, Takao ; Bando, Rui ; Yoshihashi, Yasuo ; Yonemochi, Etsuo ; Fujii, Kotaro ; Uekusa, Hidehiro ; Terada, Katsuhide</creator><creatorcontrib>Hasegawa, Gen ; Komasaka, Takao ; Bando, Rui ; Yoshihashi, Yasuo ; Yonemochi, Etsuo ; Fujii, Kotaro ; Uekusa, Hidehiro ; Terada, Katsuhide</creatorcontrib><description>Thermodynamic stability order of tolbutamide between polymorphs was evaluated using calorimetry and spectroscopic analysis. The heat of solution (Δ H) of Forms I–III measurements were carried out in dimethylsulfoxide between 298.2 K and 319.2 K. It was found that the Δ H of Forms II and III was increased nearly parallel with a temperature rise. However, change of the Δ H of Form I with a temperature rise was not in correspondence with that of other forms. Solubility data confirmed the change in Δ H of Form I around 308.2 K. XRD–DSC measurement of Form I detected a polymorphic transformation (Form I L → unknown form) at 311 K. Obtained data suggested that the new crystal form (Form I H) would exist above 311 K, and the order of thermodynamic stability was “Form III &lt; Form I L &lt; Form II” below the transition temperature, on the other hand, the order was changed in “Form I L and Form I H &lt; Form III &lt; Form II” above the transition temperature. The crystal structure of Form I H was determined by measurement of PXRD pattern on BL19B2 at SPring-8, and the change in the solid-state NMR spectrum confirmed the transformation of the crystal structure of Form I L.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2008.10.018</identifier><identifier>PMID: 19026732</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Biological and medical sciences ; Calorimetry, Differential Scanning ; Crystallization ; Drug Stability ; General pharmacology ; Hypoglycemic Agents - chemistry ; Medical sciences ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polymorphic transformation ; Solid-state NMR ; Solubility ; Structure determination from PXRD data ; Temperature ; Thermodynamics ; Tolbutamide ; Tolbutamide - chemistry ; X-Ray Diffraction</subject><ispartof>International journal of pharmaceutics, 2009-03, Vol.369 (1), p.12-18</ispartof><rights>2008 Elsevier B.V.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-c82a2c2c8882493eaa0e82c82c559e95bbe03a703c220a912b432d63d14f33c43</citedby><cites>FETCH-LOGICAL-c503t-c82a2c2c8882493eaa0e82c82c559e95bbe03a703c220a912b432d63d14f33c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2008.10.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21266254$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19026732$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasegawa, Gen</creatorcontrib><creatorcontrib>Komasaka, Takao</creatorcontrib><creatorcontrib>Bando, Rui</creatorcontrib><creatorcontrib>Yoshihashi, Yasuo</creatorcontrib><creatorcontrib>Yonemochi, Etsuo</creatorcontrib><creatorcontrib>Fujii, Kotaro</creatorcontrib><creatorcontrib>Uekusa, Hidehiro</creatorcontrib><creatorcontrib>Terada, Katsuhide</creatorcontrib><title>Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Thermodynamic stability order of tolbutamide between polymorphs was evaluated using calorimetry and spectroscopic analysis. The heat of solution (Δ H) of Forms I–III measurements were carried out in dimethylsulfoxide between 298.2 K and 319.2 K. It was found that the Δ H of Forms II and III was increased nearly parallel with a temperature rise. However, change of the Δ H of Form I with a temperature rise was not in correspondence with that of other forms. Solubility data confirmed the change in Δ H of Form I around 308.2 K. XRD–DSC measurement of Form I detected a polymorphic transformation (Form I L → unknown form) at 311 K. Obtained data suggested that the new crystal form (Form I H) would exist above 311 K, and the order of thermodynamic stability was “Form III &lt; Form I L &lt; Form II” below the transition temperature, on the other hand, the order was changed in “Form I L and Form I H &lt; Form III &lt; Form II” above the transition temperature. The crystal structure of Form I H was determined by measurement of PXRD pattern on BL19B2 at SPring-8, and the change in the solid-state NMR spectrum confirmed the transformation of the crystal structure of Form I L.</description><subject>Biological and medical sciences</subject><subject>Calorimetry, Differential Scanning</subject><subject>Crystallization</subject><subject>Drug Stability</subject><subject>General pharmacology</subject><subject>Hypoglycemic Agents - chemistry</subject><subject>Medical sciences</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymorphic transformation</subject><subject>Solid-state NMR</subject><subject>Solubility</subject><subject>Structure determination from PXRD data</subject><subject>Temperature</subject><subject>Thermodynamics</subject><subject>Tolbutamide</subject><subject>Tolbutamide - chemistry</subject><subject>X-Ray Diffraction</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1q3DAURkVpaKZpH6FFm3bniX4sWV6FEpo2ECiEZC1k-ZpoKluuJKfM20dmTLrsSnyX811dDkKfKNlTQuXlYe8O85OJ454RospsT6h6g3ZUNbzidSPfoh3hjaoEbfg5ep_SgRAiGeXv0DltCZMNZzvk7wGejV9MdmHCYcAp-KVz3uXjmnLw3ZLN6HrAZurxHPxxDHF-chbnaKY0hDieukMMI74pEd-WGl6m31P4O2Ebjykbj1fwAzobjE_wcXsv0OPN94frn9Xdrx-319_uKisIz5VVzDDLrFKK1S0HYwioEpkVooVWdB0QbhrCLWPEtJR1NWe95D2tB85tzS_Q19PeOYY_C6SsR5cseG8mCEvSUrZKCEoKKE6gjSGlCIOeoxtNPGpK9KpZH_SmWa-a13HRXHqftw-WboT-X2vzWoAvG2CSNX4oqqxLrxyjTEom1kuvThwUHc8Ook7WwWShdxFs1n1w_znlBREXn8c</recordid><startdate>20090318</startdate><enddate>20090318</enddate><creator>Hasegawa, Gen</creator><creator>Komasaka, Takao</creator><creator>Bando, Rui</creator><creator>Yoshihashi, Yasuo</creator><creator>Yonemochi, Etsuo</creator><creator>Fujii, Kotaro</creator><creator>Uekusa, Hidehiro</creator><creator>Terada, Katsuhide</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090318</creationdate><title>Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form</title><author>Hasegawa, Gen ; Komasaka, Takao ; Bando, Rui ; Yoshihashi, Yasuo ; Yonemochi, Etsuo ; Fujii, Kotaro ; Uekusa, Hidehiro ; Terada, Katsuhide</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-c82a2c2c8882493eaa0e82c82c559e95bbe03a703c220a912b432d63d14f33c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Calorimetry, Differential Scanning</topic><topic>Crystallization</topic><topic>Drug Stability</topic><topic>General pharmacology</topic><topic>Hypoglycemic Agents - chemistry</topic><topic>Medical sciences</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymorphic transformation</topic><topic>Solid-state NMR</topic><topic>Solubility</topic><topic>Structure determination from PXRD data</topic><topic>Temperature</topic><topic>Thermodynamics</topic><topic>Tolbutamide</topic><topic>Tolbutamide - chemistry</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasegawa, Gen</creatorcontrib><creatorcontrib>Komasaka, Takao</creatorcontrib><creatorcontrib>Bando, Rui</creatorcontrib><creatorcontrib>Yoshihashi, Yasuo</creatorcontrib><creatorcontrib>Yonemochi, Etsuo</creatorcontrib><creatorcontrib>Fujii, Kotaro</creatorcontrib><creatorcontrib>Uekusa, Hidehiro</creatorcontrib><creatorcontrib>Terada, Katsuhide</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasegawa, Gen</au><au>Komasaka, Takao</au><au>Bando, Rui</au><au>Yoshihashi, Yasuo</au><au>Yonemochi, Etsuo</au><au>Fujii, Kotaro</au><au>Uekusa, Hidehiro</au><au>Terada, Katsuhide</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2009-03-18</date><risdate>2009</risdate><volume>369</volume><issue>1</issue><spage>12</spage><epage>18</epage><pages>12-18</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Thermodynamic stability order of tolbutamide between polymorphs was evaluated using calorimetry and spectroscopic analysis. The heat of solution (Δ H) of Forms I–III measurements were carried out in dimethylsulfoxide between 298.2 K and 319.2 K. It was found that the Δ H of Forms II and III was increased nearly parallel with a temperature rise. However, change of the Δ H of Form I with a temperature rise was not in correspondence with that of other forms. Solubility data confirmed the change in Δ H of Form I around 308.2 K. XRD–DSC measurement of Form I detected a polymorphic transformation (Form I L → unknown form) at 311 K. Obtained data suggested that the new crystal form (Form I H) would exist above 311 K, and the order of thermodynamic stability was “Form III &lt; Form I L &lt; Form II” below the transition temperature, on the other hand, the order was changed in “Form I L and Form I H &lt; Form III &lt; Form II” above the transition temperature. The crystal structure of Form I H was determined by measurement of PXRD pattern on BL19B2 at SPring-8, and the change in the solid-state NMR spectrum confirmed the transformation of the crystal structure of Form I L.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19026732</pmid><doi>10.1016/j.ijpharm.2008.10.018</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2009-03, Vol.369 (1), p.12-18
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_66985510
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Biological and medical sciences
Calorimetry, Differential Scanning
Crystallization
Drug Stability
General pharmacology
Hypoglycemic Agents - chemistry
Medical sciences
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polymorphic transformation
Solid-state NMR
Solubility
Structure determination from PXRD data
Temperature
Thermodynamics
Tolbutamide
Tolbutamide - chemistry
X-Ray Diffraction
title Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A06%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reevaluation%20of%20solubility%20of%20tolbutamide%20and%20polymorphic%20transformation%20from%20Form%20I%20to%20unknown%20crystal%20form&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Hasegawa,%20Gen&rft.date=2009-03-18&rft.volume=369&rft.issue=1&rft.spage=12&rft.epage=18&rft.pages=12-18&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2008.10.018&rft_dat=%3Cproquest_cross%3E66985510%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66985510&rft_id=info:pmid/19026732&rft_els_id=S0378517308007291&rfr_iscdi=true